David Rosen 大卫·罗森

Greater Chicago Area, Illinois United States

Founder & President @ Serenium™ - SDB Screening Biomarkers,DX Sensors, Point of Care, Direct to Consumers)

Medical / Health Care / Pharmaceuticals

Serenium™ is a revolutionary new health care business based on over 15 years of clinically and statistically validated research and development. It is now ready and available for global commercialization. Serenium is targeting 500,000,000 plus consumers in the US and China alone, and will achieve sales in excess of $ 1,000,000,000 by 2025. Serenium’s innovative solutions focus on early identification and intervention for respiratory related disorders, long before they result in the chronic, non-curable disease states such as hypertension, diabetes, ADHD, impotence, and anxiety disorders to which they have been associated . By allowing such early intervention, one can inexpensively